Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 7, 2013 - Issue
Submit an article Journal homepage
62
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Effect of Tianqi antitremor granules on behavioral manifestations and expression of G protein-coupled receptor kinase 6 and β-arrestin1 in levodopa-induced dyskinesia in a rat model of Parkinson’s disease

Na Wu1 Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, People’s Republic of China
,
Xinxin Yang1 Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, People’s Republic of China
,
Lu Song1 Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, People’s Republic of China
,
Jianglei Wei2 Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China
&
Zhenguo Liu1 Department of Neurology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, People’s Republic of ChinaCorrespondence[email protected]
Pages 1481-1489 | Published online: 10 Dec 2013

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Liqian Mo, Xiaoyan Xiao, Shaolian Song, Hui Miao, Shiting Liu, Dan Guo, Xiao Li, Can Bu, Lianbing Hou & Xixiao Yang. (2015) Protective effect of Huang Gan formula in 5/6 nephrectomized rats by depressing the Wnt/β-catenin signaling pathway. Drug Design, Development and Therapy 9, pages 2867-2881.
Read now

Articles from other publishers (3)

Zhihua Liu, Jiahao Zhao, Shuyuan Yang, Yu Zhang, Lu Song, Na Wu & Zhenguo Liu. (2022) Network Pharmacology and Absolute Bacterial Quantification-Combined Approach to Explore the Mechanism of Tianqi Pingchan Granule Against 6-OHDA-Induced Parkinson’s Disease in Rats. Frontiers in Nutrition 9.
Crossref
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Ruibing Wang, Simon Ming-Yuen Lee & Ying Zheng. (2017) Small-Sized mPEG–PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity. ACS Applied Materials & Interfaces 9:11, pages 9516-9527.
Crossref
Tongkai Chen, Chuwen Li, Ye Li, Xiang Yi, Simon Ming-Yuen Lee & Ying Zheng. (2016) Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson’s Disease. Molecular Pharmaceutics 13:11, pages 3864-3875.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.